首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   476篇
  免费   28篇
  国内免费   14篇
  2023年   8篇
  2022年   14篇
  2021年   16篇
  2020年   15篇
  2019年   11篇
  2018年   12篇
  2017年   9篇
  2016年   6篇
  2015年   23篇
  2014年   48篇
  2013年   44篇
  2012年   50篇
  2011年   46篇
  2010年   48篇
  2009年   27篇
  2008年   16篇
  2007年   21篇
  2006年   15篇
  2005年   11篇
  2004年   16篇
  2003年   17篇
  2002年   8篇
  2001年   5篇
  2000年   2篇
  1999年   4篇
  1998年   2篇
  1997年   4篇
  1996年   3篇
  1995年   5篇
  1994年   1篇
  1993年   2篇
  1992年   1篇
  1991年   2篇
  1990年   1篇
  1987年   2篇
  1986年   1篇
  1984年   1篇
  1980年   1篇
排序方式: 共有518条查询结果,搜索用时 15 毫秒
91.
92.
目的:探讨不同剂量瑞舒伐他汀对急性冠脉综合征患者(ACS)炎症反应及预后的影响。方法:选择2014年5月至2015年10月间收治的120例ACS患者为研究对象,随机分为A、B、C三组,每组40例。所有患者先给予常规治疗,A组患者给予20mg/d普伐他汀治疗;B组患者给予10 mg/d瑞舒伐他汀;C组患者给予20 mg/d瑞舒伐他汀,3组均持续治疗6个月。比较3组患者治疗前后血脂、超敏C反应蛋白(hs-CRP)、肿瘤坏死因子-α(TNF-α)、白介素-6(IL-6)的水平;随访6个月心血管事件发生情况。结果:3组患者治疗后hs-CRP、TNF-α、IL-6水平均明显下降,且C组下降最明显,其次为B组,比较差异均有统计学意义(P0.05);治疗后血脂水平均的改善,且C组改善最明显,其次是B组,比较差异均有统计学意义(P0.05);随访6个月,C组心血管事件发生率为2.5%,远低于B组(10.0%)及A组(20.0%),差异具有显著性(P0.05)。结论:大剂量(20 mg/d)瑞舒伐他汀治疗ACS降脂、抗炎效果明显,预后相对较好,值得临床推广使用。  相似文献   
93.
A rhesus monkey fetus was examined by ultrasound at 110, 111, and 113 gestational days (GD) and showed features suggestive of Amniotic Band Syndrome (ABS). These included an unusual craniofacial configuration, cortical distortion, asymmetrical hydrocephalus, a right occipital porencephalic cyst, and hydropic membranes with several free strands attached to the fetal head, neck, and scapular regions. The fetus remained fixed in the same position with the head retroflexed during each consecutive exam. A hysterotomy was performed and ABS was confirmed.  相似文献   
94.
采用间接免疫荧光法(IFA)和ELISA法比较了几株中国和日本流行性出血热病毒(EHFV)的抗原性,IFA法不能区分大鼠属和姬鼠属来源的病毒,ELISA竞争试验表明,大鼠型病毒(R22、SR-11和TR-352株)与姬鼠型病毒(A 9株)存在弱单向交叉反应,交叉ELISA证实,A 9株与R22株、SR-11株和TR-352株均有较显著的抗原性差异,但R22,SR-11和TR-352株彼此间抗原性相近,本文讨论了有关EHFV抗原性比较中的一些问题。  相似文献   
95.
Increasing adipocyte size as well as numbers is important in the development of obesity and type 2 diabetes, with adipocytes being generated from mesenchymal precursor cells. This process includes the determination of mesenchymal stem cells (MSC) into preadipocytes (PA) and the differentiation of PA into mature fat cells. Although the process of differentiation has been highly investigated, the determination in humans is poorly understood. In this study, we compared human MSC and human committed PA on a cellular and molecular level to gain further insights into the regulatory mechanisms in the determination process. Both cell types showed similar morphology and expression patterns of common mesenchymal and hematopoietic surface markers. However, although MSC were able to differentiate into adipocytes and osteocytes, PA were only able to undergo adipogenesis, indicating that PA lost their multipotency during determination. WNT-5a expression showed significantly higher levels in MSC compared with PA suggesting that WNT-5a down-regulation might be important in the determination process. Indeed, incubation of human MSC in medium containing neutralizing WNT-5a antibodies abolished their ability to undergo osteogenesis, although adipogenesis was still possible. An opposite effect was achieved using recombinant WNT-5a protein. On a molecular level, WNT-5a was found to promote c-Jun N-terminal kinase-dependent intracellular signaling in MSC. Activation of this noncanonical pathway resulted in the induction of osteopontin expression further indicating pro-osteogenic effects of WNT-5a. Our data suggest that WNT-5a is necessary to maintain osteogenic potential of MSC and that inhibition of WNT-5a signaling therefore plays a role in their determination into PA in humans.  相似文献   
96.
  1. Download : Download high-res image (343KB)
  2. Download : Download full-size image
Highlights
  • •Matrisome content significantly changes with development and perlecan knockdown.
  • •Chondrocytes respond to perlecan deficiency by increasing bulk matrisome secretion.
  • •Decreased stiffness may be explained by atypical glycosaminoglycan deposition.
  • •Elevated COL10A1 expression and chondrocyte hypertrophy indicate early ossification.
  相似文献   
97.
98.
摘要 目的:研究二甲双胍联合炔雌醇环丙孕酮片治疗多囊卵巢综合征(polycystic ovarian syndrome,PCOS)患者的临床疗效及对患者糖脂代谢的影响。方法:选取2018年1月~2020年12月在我院接受治疗的60例PCOS患者作为研究对象,随机数表法均分为对照组和研究组:对照组患者接受炔雌醇环丙孕酮片治疗,而研究组患者接受二甲双胍联合炔雌醇环丙孕酮片治疗。比较两组患者治疗后排卵和妊娠情况,并比较治疗前后性激素水平和糖脂代谢的变化。结果:研究组治疗总有效率为83.33%,显著高于对照组63.33%的治疗总有效率(P<0.05)。治疗前,两组患者血清卵泡刺激素(Follicle Stimulating Hormone, FSH)、黄体生成素(Luteinizing hormone, LH)、雌二醇(Estradiol, E2)、睾酮(Testosterone, T)等性激素水平,空腹血糖(fasting plasma glucose, FPG)、空腹胰岛素(Fasting serum lisulin, FINS)、口服葡萄糖耐量试验(oral glucose tolerance test, OGTT)2 h血糖和胰岛素等糖代谢指标以及甘油三酯(Triglycerides, TG)、胆固醇(Total cholesterol, TC)、高密度脂蛋白(High density lipoprotein, HDL)和低密度脂蛋白(Low density lipoprotein, LDL)等脂代谢指标脂代谢指标比较均无显著差异(P>0.05);治疗后,所有患者血清FSH、LH、T、E2、TG、LDL、TC、FPG、FINS、OGTT 2h PG和OGTT 2h INS均较治疗前显著降低(P<0.05),而HDL较治疗前升高(P<0.05);研究组患者治疗后血清FSH、LH、T、E2、TG、LDL、TC、FPG、FINS、OGTT 2h PG和OGTT 2h INS均较显著低于对照组患者(P<0.05),而HDL显著高于对照组患者(P<0.05)。结论:二甲双胍联合炔雌醇环丙孕酮片治疗多囊卵巢综合征临床效果显著,可有效改善患者糖脂代谢水平。  相似文献   
99.
100.
The connection between Netherton syndrome and overactivation of epidermal/dermal proteases, particularly Kallikrein 5 (KLK5) has been well established and it is expected that a KLK5 inhibitor would improve the dermal barrier and also reduce the pain and itch that afflict Netherton syndrome patients. One of the challenges of covalent protease inhibitors has been achieving selectivity over closely related targets. In this paper we describe the use of structural insight to design and develop a selective and highly potent reversibly covalent KLK5 inhibitor from an initial weakly binding fragment.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号